Inactive Instrument
Probi AB Stock OTC Markets
Stocks
PBBIF
SE0001280355
Pharmaceuticals
OTC Markets Traded| 1 day | +31.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 2022-12-07 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 2025-07-31 |
James Henson
COO | Chief Operating Officer | 39 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2020-05-12 | |
| Chairman | 62 | 2015-03-31 | |
| Director/Board Member | 64 | 2017-05-03 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +31.67% | +85.88% | - | - | 33.68M | |
| -2.33% | +0.53% | +51.65% | +115.42% | 1,056B | |
| -1.06% | -1.65% | +42.78% | +69.98% | 645B | |
| -0.65% | -1.32% | +12.98% | +75.49% | 465B | |
| -2.66% | -1.87% | +73.13% | +41.15% | 368B | |
| -0.06% | -3.88% | +34.32% | +39.39% | 335B | |
| -0.79% | +2.01% | +19.82% | +27.79% | 275B | |
| -1.19% | -1.21% | +9.82% | +10.61% | 255B | |
| -0.50% | +3.80% | +49.37% | +56.84% | 229B | |
| -1.47% | -1.53% | +34.28% | +98.89% | 188B | |
| Average | +2.41% | -0.18% | +36.46% | +59.51% | 423.98B | |
| Weighted average by Cap. | -1.02% | -0.23% | +39.91% | +71.39% |
Employees
-
Sector
Pharmaceuticals
